EDEN PRAIRIE, Minn. (BUSINESS WIRE) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its third quarter ended June 30, 2023, and updated its financial guidance for its fiscal year ending Septemb.
As Canada prepares to expand assisted suicide, advocates warn of threat to mentally ill myspiritfm.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from myspiritfm.com Daily Mail and Mail on Sunday newspapers.
By Dean Seal Surmodics has received approval from the U.S. Food and Drug Administration for its SurVeil drug-coated balloon to be used in unblocking blood vessels. The medical device. | June 20, 2023
SurModics (SRDX) Granted FDA Approval for the SurVeil Drug-Coated Balloon streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.